Background. Specialty PCR testing has become available for lumbar puncture to determine the cause of infectious meningitis and encephalitis. Testing with low pre-test probability may increase antimicrobial therapy while results are pending and create increased direct costs. We aim to describe the appropriateness of testing before and after the implementation of electronic medical record (EMR) order sets designed to reduce excessive testing of CSF by creating two lists of tests: (1) a routine panel for all patients and (2) a list of optional specialty tests designed to be utilized after the nucleated cells are resulted.
Methods. Retrospective study of adult patients undergoing lumbar puncture with suspicion for CNS infection pre-and post-implementation of EMR order sets from January 2016-March 2017. Consecutive patients with complete charts were reviewed from a tertiary care center. Data collected included demographics, co-morbid conditions, clinical presentation, and lumbar puncture results. The primary outcome of interest was the frequency of CSF specialty testing in patients with ≤ 10 nucleated cells/ µL in the CSF.
Results. Two hundred patients had ≤ 10 nucleated cells/µL in the CSF (n = 108 in pre-EMR group; n = 92 in post-EMR group). Of these patients 74% and 48.9% had Herpes Simplex Virus (HSV) PCR testing done pre and post EMR changes (P < 0.05). Enterovirus PCR testing remained similar among both groups (37% pre-EMR order sets vs. 36.9% post-EMR order sets, P = 0.99). Lyme PCR testing decreased between pre-and post-groups (26.8% vs. 9.7%, P < 0.05). CSF Epstein-Barr virus PCR testing also dropped significantly from 26.9% to 7.6% (P < 0.05). All specialty PCR testing that was performed on patients with ≤ 10 nucleated cells/µL in the CSF were negative. Paradoxically, HSV antibody testing increased post-implementation of EMR order sets (21.7% vs. 0%, P <0.05). Total costs of tests on average decreased by $70.71 per patient post EMR changes.
Conclusion.
In this cohort, CSF specialty testing was common but decreased after EMR changes. Laboratory stewardship can be improved with EMR changes but further education is needed to prevent unnecessary tests. Unwanted tests (HSV antibodies) may be increased as prescribers are unable to locate familiar tests. Background. Brain abscess develops in response to a parenchymal infection due to pyogenic bacteria. MMPs (matrix metalloproteinases) play vital role in many infectious and central nervous system (CNS) diseases. The present study evaluated the association of specific alleles/ genotypes of MMP-1, -2, -3, and -9 with brain abscess.
Methods. A total of 100 brain abscess patients and 100 healthy controls were included in the study. Predisposing factors were identified in 70 brain abscess patients. Out of 100 brain abscess samples, 66 were culture positive. MMP-1-1607 1G/2G, MMP-2-C-1306-T, MMP-3 -1171 5A/6A, and MMP-9 C-1562Tgenotypes were detected by PCR-RFLP. Levels of these MMPs were determined in patients' sera by ELISA and correlated with different genotypes.
Results. The genotypic distributions of MMP-1-1607 1G/2G, MMP-2-C-1306-T, MMP-3 -1171 5A/6A, and MMP-9 C-1562T were significantly different between patients and controls. Homozygous genotype of MMP-1, -3, and -9 (P < 0.001, P = 0.04, and P = 0.03, respectively) and heterozygous genotype of MMP-2 (P < 0.001) showed significant association with brain abscess. Individuals with mutant genotypes had elevated levels of these MMPs. Furthermore, heterozygous (5A/6A and C/T, respectively) genotypes of MMP-3 and -9 also showed significant association with brain abscess patients having predisposing factors. When comparison was made between culture positive and culture negative results, of MMP-1 2G/2G and MMP-9 T/T, C/T genotype showed significant association with culture positive patients Conclusion. Polymorphism of MMP-1-1607 1G/2G, MMP-2-C-1306-T, MMP-3 -1171 5A/6A, and MMP-9 C-1562T polymorphisms lead to increased production of these molecules, which appear to be a risk for the development of brain abscess in North Indian population.
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The Etiologies and Clinical Characteristics of Patients Hospitalized with an Acute Febrile Illness and Central Nervous System Sydromes in Indonesia
Results. Subject ages ranged from 1 to 63.2 years old (median of 4.9 years old), and underlying diseases were reported in 35 (30.7%) subjects. Standard-ofcare, molecular, and serological testing identified pathogens in 56 (49.1%) cases, as detailed in the table. Of the 19 subjects who died, 18 presented with decreased consciousness and 5 were infected with Rickettsia typhi, which was clinically misdiagnosed in each case.
Conclusion. The findings from this study will improve the diagnosis and treatment of patients presenting with CNS syndromes in Indonesia. Additionally, the discovery of misdiagnosed, fatal etiologies highlights the general need for greater diagnostic testing capacity to aid clinicians and inform public health policy makers.
Acute febrile patients with neurological signs and symptoms Consciousness status (n)
Normal (61) Decreased (53) Mortality (%) 1.6 34
End-of-study status (n) Discharged (60) Died (1) Discharged (35) Died (18) Etiology (n) Unknown (32) Unknown (1) Unknown (16) Unknown (9) HHV-6 (9) Dengue (5) R. typhi (5) Dengue (8) HHV-6 (3) Dengue (1) Chikungunya (5) Influenza (2) Influenza (1 
